NGM Biopharmaceuticals
Sep 04, 2024
Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH)
Nonalcoholic Steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD), characterized by liver inflammation and damage due to fat accumulation. Unlike simple fatty liver, NASH can progress to serious conditions such as fibrosis, cirrhosis, and liver failure. This chronic liver disease is i...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
